1. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC
   Edward Zheng et al, 2024, Frontiers in Surgery CrossRef
2. Gene Mutational Clusters in the Tumors of Colorectal Cancer Patients With a Family History of Cancer
   He Huang et al, 2022, Frontiers in Oncology CrossRef
3. Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox
   Dirk H. Siepe et al, 2023, ACS Synthetic Biology CrossRef
4. Clinical associations and genetic interactions of oncogenic BRAF alleles
   Sebastian A. Wagner, 2022, PeerJ CrossRef
5. RNF43 in cancer: Molecular understanding and clinical significance in immunotherapy
   Xingfa Huo et al, 2024, The Journal of Gene Medicine CrossRef
6. RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy
   Tomasz Radaszkiewicz et al, 2021, eLife CrossRef
7. RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer
   Peipei Shang et al, 2023, Frontiers in Oncology CrossRef